Pro-Life Groups Oppose FDA Nominee Califf
A coalition of pro-life organizations expressed opposition Wednesday to the confirmation of President Joe Biden’s choice to run the Food and Drug Administration, saying the nominee has used selective research to push approval of mail-order abortion pills and to ignore their risks. The Senate Health, Education, Labor, and Pensions Committee is scheduled to vote on Biden’s nomination of Dr. Robert Califf to be FDA commissioner. Califf previously served in the position during the final 11 months of President Barack Obama’s administration, from Feb. 22, 2016, to Jan. 20, 2017. If confirmed by the full Senate, Califf would replace Dr. Janet Woodcock, who has served as the acting commissioner for the past year. Read more...